跳至主要内容
临床试验/CTIS2024-516266-11-00
CTIS2024-516266-11-00进行中(未招募)1 期

Prospective multicenter randomized double-blind study comparing caspofungin to placebo for the treatment of ICU yeast intra-abdominal infection - PI2018_843_0007

Centre Hospitalier Universitaire Amiens Picardie0 个研究点目标入组 448 人开始时间: 2024年7月29日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
448

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Age = 18 years old, Covered by national health insurance, Admitted to ICU after surgery for intra-abdominal infection : - With suspected intra-abdominal candidiasis defined by a Peritonitis score = 3 - Or with documented intra-abdominal candidiasis defined by positive direct examination or positive culture of peritoneal fluid collected intraoperatively, With written and signed informed consent

排除标准

  • Allergy to caspofungin, Life expectancy = 48h, Expected withdrawal of treatment, Radiological drainage without surgery, Severe hepatic impairment (Child-Pugh C score), Pregnant or lactating women

研究者

相似试验